NCT02791854
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Enrolling by Invitation
Not specifiedAges 18–99ObservationalDartmouth-Hitchcock Medical CenterInvestigator-initiated
~10,000 participants
Updated 2025-08-21 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 29 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients enrolled
Measured over annually, up to 5 years
Conditions
Where it's being run
29 sites across 20 statesNew York5
California3
Florida2
Pennsylvania2
Texas2
Colorado1
Connecticut1
District of Columbia1
Study leadership
- Corey Siegel, MD, MS · PRINCIPAL_INVESTIGATOR · Dartmouth-Hitchcock Medical Center
- Gil Melmed, MD, MS · PRINCIPAL_INVESTIGATOR · Cedars-Sinai Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
18 years of age or older
Diagnosis of Crohn's disease or ulcerative colitis or IBD unclassified
Accept the terms and conditions of Informed Consent and Authorization
Affiliated with a participating IBD Qorus site
Exclusion
Inability to provide informed consent
Study key personnel cannot enroll as a study participant
What this trial measures
- Number of patients enrolledannually, up to 5 years
count of number of patients consented